Blume Capital Management Inc. Has $957,000 Position in UnitedHealth Group Incorporated $UNH

Key Points

• Blume Capital Management Inc. increased its holdings in UnitedHealth Group by 954.3% in Q2, now owning shares valued at $957,000.
• Analyst ratings are mixed, with 18 analysts$425.00.
• UnitedHealth Group announced a quarterly dividend of $2.21 per share, resulting in an annualized yield of 2.4% based on a payout ratio of 38.30%.

Blume Capital Management Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 954.3% in the second quarter, according to its most recent filing with the SEC. The firm owned 3,068 shares of the healthcare conglomerate's stock after acquiring an additional 2,777 shares during the period. Blume Capital Management Inc.'s holdings in UnitedHealth Group were worth $957,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently added to or reduced their stakes in UNH. Gables Capital Management Inc. boosted its stake in UnitedHealth Group by 219.8% in the 2nd quarter. Gables Capital Management Inc. now owns 4,065 shares of the healthcare conglomerate's stock valued at $1,268,000 after buying an additional 2,794 shares in the last quarter. Cullen Frost Bankers Inc. boosted its stake in shares of UnitedHealth Group by 4.8% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 108,986 shares of the healthcare conglomerate's stock valued at $34,000,000 after purchasing an additional 4,955 shares in the last quarter. St. Johns Investment Management Company LLC grew its holdings in shares of UnitedHealth Group by 38.1% in the 2nd quarter. St. Johns Investment Management Company LLC now owns 3,592 shares of the healthcare conglomerate's stock worth $1,121,000 after purchasing an additional 991 shares during the last quarter. Coronation Fund Managers Ltd. bought a new stake in UnitedHealth Group during the second quarter worth about $12,436,000. Finally, Beech Hill Advisors Inc. bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $2,254,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the subject of a number of recent analyst reports. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an "overweight" rating in a report on Thursday, October 9th. Barclays raised their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an "overweight" rating in a research report on Thursday, October 9th. Weiss Ratings reissued a "sell (d+)" rating on shares of UnitedHealth Group in a research note on Wednesday, October 8th. Finally, UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Hold" and a consensus target price of $385.13.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $365.47 on Wednesday. The firm's 50 day moving average price is $333.70 and its two-hundred day moving average price is $341.28. The stock has a market cap of $331.00 billion, a PE ratio of 15.83, a PEG ratio of 2.36 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's payout ratio is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.